# Sparkasse Ulm

> Sparkasse Ulm is a VC fund in Denzlingen backing Medical, Health Care and Medical Device. See 2 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Denzlingen, Germany
- Total investments: 2
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sparkasse-ulm/?originalSubdomain=de
- Website: https://www.sparkasse-ulm.de/de/home.html
- Facebook: https://www.facebook.com/spkulm

Sparkasse Ulm is a VC fund in Denzlingen focused on Medical and Health Care. Sparkasse Ulm is provides banking services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NVision Quantum Technologies | NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $26.1M | Series B | Dec 20, 2024 | https://www.nvision-imaging.com/ |
| NVision Quantum Technologies | NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $30M | Series A | Jun 22, 2023 | https://www.nvision-imaging.com/ |

2 of 2 investments shown.

## Co-investors
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 2 deals together
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund, 2 deals together
- [Playground Global](https://shizune.co/investors/profile/playground-global) — VC Fund, 2 deals together
- [ES KAPITAL](https://shizune.co/investors/profile/es-kapital) — VC Fund, 1 deal together
- [Lauder Partners](https://shizune.co/investors/profile/lauder-partners) — VC Fund, 1 deal together
- [Pathena](https://shizune.co/investors/profile/pathena) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Germany](https://shizune.co/investors/medical-device-investors-germany)
- [Medical Device VC Funds in Germany](https://shizune.co/investors/medical-device-vc-funds-germany)

## FAQ

### What does Sparkasse Ulm invest in?

Sparkasse Ulm invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sparkasse Ulm last invest?

The most recent investment recorded for Sparkasse Ulm closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co